Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications

Memorial Sloan Kettering Cancer Center1 site in 1 country28 target enrollmentJune 28, 2016

ConditionsSarcoma Lung Solid Tumor Gastrointestinal

Overview

Phase: N/A
Intervention: Not specified
Conditions: Sarcoma
Sponsor: Memorial Sloan Kettering Cancer Center
Enrollment: 28
Locations: 1
Primary Endpoint: objective pill count
Status: Completed
Last Updated: 7 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This study is being done to determine if sending reminder text messages helps patients take their Oral Anticancer Medication (OAMs) when they are supposed to.

Registry

clinicaltrials.gov

Start Date

June 28, 2016

End Date

November 14, 2018

Last Updated

7 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Memorial Sloan Kettering Cancer Center

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patient in the Sarcoma, Solid Tumor Gastrointestinal (ST GI), and Thoracic Medicine service at MSK.
•Starting a new treatment regimen that includes a single oral anticancer medication
•Patients must have a mobile phone that can send and receive SMS/MMS messages and is internet-enabled.
•Age 18 or older.
•Ability to speak and read English because we do not have the resources to translate the text messages into other languages.

Exclusion Criteria

•Patient expresses inability or unfamiliarity with using SMS/MMS messaging on their phone and is unwilling to be trained in the use of this technology.